Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection. - Wikidata - awgldk - TriplyDB

Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.

Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.

http://www.wikidata.org/entity/Q34594547

about

Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures On the stability of parainfluenza virus 5 F proteins.Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement Measles fusion machinery is dysregulated in neuropathogenic variants.Features of Circulating Parainfluenza Virus Required for Growth in Human Airway.Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides.Biophysical Properties and Antiviral Activities of Measles Fusion Protein Derived Peptide Conjugated with 25-Hydroxycholesterol.Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation.

P2860

Q28551477-5E40F26E-6C70-462D-9994-9D4575E6AB72 Q35111025-0FCCD7B1-E535-41AC-923F-8E8B53E133AB Q35111139-7E9DCB37-EDE9-4E33-A402-A024ED6E4F21 Q35111156-BB04749B-8133-4F93-ADA8-E162D67BB7F0 Q36727644-F670158B-2B4D-4E32-9F3F-CA776DDDAD7A Q37715076-1D496016-5D9F-4385-9071-ECC064378A98 Q47582990-0ECC200F-1837-4814-837E-6F06AA02C32B Q55442083-80228E3D-0B77-4DBC-ABC8-1F4F3D49F3E4

P2860

Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.

http://www.wikidata.org/entity/Q34594547

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Circulating clinical strains o ...... rements for in vivo infection.

@ast

Circulating clinical strains o ...... rements for in vivo infection.

@en

Circulating clinical strains o ...... rements for in vivo infection.

@nl

type

label

Circulating clinical strains o ...... rements for in vivo infection.

@ast

Circulating clinical strains o ...... rements for in vivo infection.

@en

Circulating clinical strains o ...... rements for in vivo infection.

@nl

prefLabel

Circulating clinical strains o ...... rements for in vivo infection.

@ast

Circulating clinical strains o ...... rements for in vivo infection.

@en

Circulating clinical strains o ...... rements for in vivo infection.

@nl

P1433

Q34594547-28F367E9-2990-4B1C-ACE5-1666967C764F

P1476

Q34594547-E3B14E50-981B-4087-9DC4-5B3671DA1D28

P2093

Q34594547-3C485FD3-FA3B-465A-8000-D1D1F733E12B

Q34594547-7A62BFBD-EAB5-483C-8375-01F1C3F28459

Q34594547-9C7CDD4B-8DE9-4288-A654-F3A333E432C5

Q34594547-D2D50702-6B29-442F-9D94-64FCD3B73B8E

Q34594547-E22B9740-71BE-4867-9683-08D7BEA3C164

Q34594547-FF1E06D0-4F62-49C8-9173-86158502DD03

P2860

Q34594547-02195A43-CFDA-4CBE-B6E4-CC4F20812998

Q34594547-049D832F-5809-46F7-8341-832E7BE5BC74

Q34594547-097E065A-3463-403C-ADB7-8CEC4A7DAFB7

Q34594547-15FAAEEC-DFDB-4588-8985-CF8106F364E0

Q34594547-1B0FD138-B630-4BAA-A820-42A1E834C274

Q34594547-2CD0F9F7-6565-488B-B470-89BB55068060

Q34594547-37E4EDEF-98CB-4A6D-84DC-0AFE0900D752

Q34594547-39E5F046-1152-4079-A70F-1093B695A51B

Q34594547-3A9A1842-EC46-41DF-A6F6-AEAEE47798F4

Q34594547-3AF872C9-6858-4274-B126-4875B5231FC4

P304

Q34594547-CF7C5502-4FAE-4A13-92CE-C21AC2DC96F5

P31

Q34594547-0656DA90-B917-4BB9-A60F-DE886985C1D1

P356

Q34594547-E47F153C-9510-4F46-B6A3-7E917A36A0D3

P407

Q34594547-4FDBAC41-EEA7-4589-8670-AD959A468651

P433

Q34594547-580B6B6D-5858-4A41-B3AD-AF2468761098

P478

Q34594547-2D029D12-251F-45C1-9AD6-DBD9016CB909

P577

Q34594547-12635266-F341-4A26-A82A-3ED050E09FFB

P698

Q34594547-23EBE3BF-B616-44E6-94D2-C9DEBEC524BB

P932

Q34594547-592ADB87-E031-4D38-94C9-FA606A4A4DF4

P356

P1433

Journal of Virology

P1476

Circulating clinical strains o ...... rements for in vivo infection.

@en

P2093

Anne Moscona

http://www.w3.org/2001/XMLSchema#string

Ilaria DeVito

http://www.w3.org/2001/XMLSchema#string

Matteo Porotto

http://www.w3.org/2001/XMLSchema#string

Samantha G Palmer

http://www.w3.org/2001/XMLSchema#string

Stefan Niewiesk

http://www.w3.org/2001/XMLSchema#string

Stephen G Jenkins

http://www.w3.org/2001/XMLSchema#string

P2860

Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease

Potent D-peptide inhibitors of HIV-1 entry

Viral membrane fusion

Design of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance

Interaction between the Hemagglutinin-Neuraminidase and Fusion Glycoproteins of Human Parainfluenza Virus Type III Regulates Viral Growth In Vivo

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition

Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion

Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

Asymmetric deactivation of HIV-1 gp41 following fusion inhibitor binding

P304

13495-13502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01965-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25210187

http://www.w3.org/2001/XMLSchema#string

P932

4249073

http://www.w3.org/2001/XMLSchema#string